Tanke Biosciences Debt 2024

Tanke Biosciences Aktienanalyse

What does Tanke Biosciences do?

Tanke Biosciences Corp is a biopharmaceutical company specializing in the development of innovative therapies for the treatment of immune system disorders. The company was founded in 2016 and is headquartered in Beijing, China. Tanke Biosciences aims to provide patients worldwide access to high-quality medicines and improve the chances of recovery for people with serious illnesses. The business model of Tanke Biosciences is based on the discovery and development of new drugs that can be used in clinics and hospitals. The company's main focus is the research of protease inhibitors, molecules that inhibit the activity of enzymes and therefore reduce inflammation. The company has acquired world-leading expertise in the development of protease inhibitors and is one of the most promising companies in the industry in this area. Tanke Biosciences has various divisions in which the company operates. One of the most important divisions is the development of drugs for the treatment of autoimmune diseases. For this purpose, the company has developed a protease inhibitor that inhibits the activity of the protein DPP4. DPP4 is involved in the regulation of the immune system and plays an important role in the development of autoimmune diseases such as diabetes or rheumatoid arthritis. The DPP4 inhibitors of Tanke Biosciences are promising candidates for improved therapy of these diseases. Another division of Tanke Biosciences is the research of cancer therapies. For this purpose, the company has developed a protease inhibitor that inhibits the activity of the enzyme Cathepsin K. Cathepsin K is involved in the development and spread of malignant tumors and thus plays an important role in the fight against cancer. The Cathepsin K inhibitors of Tanke Biosciences are promising for the development of new cancer therapies. Tanke Biosciences also offers other products and services that serve the research of molecular drugs. These include, for example, peptide libraries that researchers can use to identify new drugs. In addition, the company offers comprehensive research services to support customers in drug discovery and development. Overall, Tanke Biosciences is an innovative biopharmaceutical company specializing in the discovery and development of new drugs for the treatment of autoimmune diseases, cancer, and other immune system disorders. With its products and services, the company makes an important contribution to improving the health of people worldwide. Tanke Biosciences ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Debt Details

Understanding Tanke Biosciences's Debt Structure

Tanke Biosciences's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing Tanke Biosciences's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to Tanke Biosciences’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in Tanke Biosciences’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about Tanke Biosciences stock

What is the debt of Tanke Biosciences this year?

Tanke Biosciences has a debt level of 0 USD this year.

What was the debt of Tanke Biosciences compared to the previous year?

The debt of Tanke Biosciences has increased by 0% compared to the previous year dropped.

What are the consequences of high debt for investors in Tanke Biosciences?

High debt can pose a risk for investors of Tanke Biosciences, as it can weaken the company's financial position and hinder its ability to fulfill its obligations.

What are the consequences of low debt for investors of Tanke Biosciences?

Low debt means that Tanke Biosciences has a strong financial position and is able to fulfill its obligations without overburdening its finances.

How does an increase in debt from Tanke Biosciences affect the company?

An increase in debt of Tanke Biosciences can adversely affect the financial condition of the company and result in a higher burden on its finances.

How does a reduction of debt of Tanke Biosciences affect the company?

A reduction in debt of Tanke Biosciences can strengthen the company's financial position and improve its ability to meet its financial obligations.

What are some factors that influence the debt of Tanke Biosciences?

Some factors that can influence the debt of Tanke Biosciences include investments, acquisitions, operating costs, and revenue development.

Why are the debts of Tanke Biosciences so important for investors?

The debts of Tanke Biosciences are important for investors as they serve as an indicator of the company's financial stability. It provides investors with information on how the company fulfills its financial obligations.

What strategic measures can Tanke Biosciences take to change the debt?

To change the debt, Tanke Biosciences can take measures such as cost savings, increasing revenue, selling assets, making investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to change its debt.

How much dividend does Tanke Biosciences pay?

Over the past 12 months, Tanke Biosciences paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Tanke Biosciences is expected to pay a dividend of 0 USD.

What is the dividend yield of Tanke Biosciences?

The current dividend yield of Tanke Biosciences is .

When does Tanke Biosciences pay dividends?

Tanke Biosciences pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Tanke Biosciences?

Tanke Biosciences paid dividends every year for the past 0 years.

What is the dividend of Tanke Biosciences?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Tanke Biosciences located?

Tanke Biosciences is assigned to the '-' sector.

Wann musste ich die Aktien von Tanke Biosciences kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Tanke Biosciences from 9/20/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 9/20/2024.

When did Tanke Biosciences pay the last dividend?

The last dividend was paid out on 9/20/2024.

What was the dividend of Tanke Biosciences in the year 2023?

In the year 2023, Tanke Biosciences distributed 0 USD as dividends.

In which currency does Tanke Biosciences pay out the dividend?

The dividends of Tanke Biosciences are distributed in USD.